ICICI Securities research report on Persistent Systems
Persistent Systems (PSYS) continues to deliver all-round impressive performance irrespective of market conditions. Management mentioned clients have become cautious and there is slight delay in conversion of pipeline to TCV. We note FY25 TCV/ACV grew 15%/13% YoY, tad lower than ~16% revenue CAGR (FY25-27) required to reach USD 2bn revenue runrate by FY27. However, management is confident of delivering industry-leading growth despite tough macros led by focusing on growing deal pipeline and pivoting to high growth areas. We raise FY26/27E EPS by 2.6%/2.8% factoring in lower tax rate and beat in Q4 partly offset by currency adjustment.
Outlook
We continue to value the stock at 35x on Q4FY26E to Q3FY27E EPS of INR 130 to arrive at TP of INR 4,550. Maintain REDUCE, given the premium valuation.
For all recommendations report, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.